Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Author's Avatar
Feb 28, 2023

Bicycle+Therapeutics+plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in March: